Recruiting PHASE2 Oral Mucositis (Ulcerative) Due to Radiation

Tests treatment safety and results for Oral Mucositis (Ulcerative) Due to Radiation

Official title Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.

ClinicalTrials.gov ID: NCT06354712

What this study is testing

What is N-Acetyl-Cysteine with Institutional standard care?

N-Acetyl-Cysteine with Institutional standard care is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for oral mucositis (ulcerative) due to radiation.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
A prospective, randomized, controlled, parallel clinical trial will be conducted at Clinical Oncology and Nuclear Medicine Center at Mansoura University Hospital to assess the efficacy of N-acetylcysteine in the prevention of radiotherapy induced oral mucositis in Head and Neck cancer patients.
  • Phase 2: a mid-size study of how well it works
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 80. Healthy volunteers may be eligible.

You may be able to join if

  • Adults \>18 years diagnosed with squamous cell carcinoma of the head and neck scheduled to receive curative radiotherapy (Primary or postoperative)...
  • Individuals with healthy mucosa.
  • Adequate bone marrow function (Hemoglobin level ≥10 g/dL, platelet count ≥75 × 103/microliter, and absolute neutrophil count ≥1.5 × 103/microliter).
  • Patients with ECOG performance ≤2

You likely can't join if

  • History of chemotherapy or radiotherapy.
  • Signs of systemic infections.
  • Pregnant and lactating women.
  • Individuals receiving systemic analgesics.
  • Liver disorders and renal failure with eGFR \<30 ml/min/1.73m2 (by the MDRD equation).
  • Inability to follow instructions and complete the questionnaires.

The study team makes the final eligibility decision.

Where it's taking place

  • Al Mansurah, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Al Mansurah, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.